Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT to Improve Immunotherapy in Metastatic Lung Cancer
NCT05502913Phase 2Recruiting
- Sponsor
- Soroka University Medical Center
- Start
- Sep 2023
- Primary completion
- Jun 2025
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of allogeneic fecal microbiota in Lung Cancer (LC), sponsored by Soroka University Medical Center. Started Sep 2023; status: recruiting.
02
Drugs
allogeneic fecal microbiota
03
Conditions
Lung Cancer (LC)
Beyond the preview
Go deeper on NCT05502913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05502913.